Comparison of Topical Corticosteroid (TCS) Phobia levels among Preclinical and Clinical Years Medical Students: Using TOPICOP Score

Background: Corticosteroid medications are commonly used in various medical conditions due to their potent anti-inflammatory and immunosuppressive properties. However, corticosteroid phobia, which refers to the fear to use these medications, can impact their appropriate use in clinical practice. Objective: This study aimed to compare the level of Topical corticosteroid (TCS) phobia among pre-clinical and clinical year medical students by using TOPICOP score. Methods: A cross-sectional study was conducted, after obtaining ethical approval, among MBBS students. A pre-tested questionnaire was used to assess TCS phobia, which included knowledge, attitudes, and beliefs about corticosteroids, as well as comfort level in prescribing or administering these in hypothetical clinical scenarios. Data was analyzed using descriptive and inferential statistics, including chi-square test. Results: The study surveyed 286 medical students; 139 of them were Pre-Clinical years students (48.6%), while 147 in Clinical (51.4%). Mean age in Pre-Clinical years was 18.7+1.2 while 21.2+2.8 in Clinical years & 51.4% reported studying pharmacology, which is the subject educating most on the various effects of TCS. Significant findings include: Clinical years students express more concern about TCS affecting future health (26.53% vs 14.39%); Clinical years students are more afraid of applying TCS on thinner skin areas (25.85% vs 21.58%); Clinical years students are more likely to stop TCS treatment early (26.53% vs 10.07%); Clinical years students are more inclined towards non-steroidal alternatives even if more expensive (25.17% vs 14.39%); and Clinical years students perceive more benefit from TCS use (21.09% vs 9.35%). Conclusion: Our findings highlighted a greater sense of caution held by Clinical Years, regarding use of TCS and its potential side effects, while still appreciating its therapeutic role